Authors: Junghans, U Seitz, RJ Aulich, A Freund, HJ Siebler, M

Citation: U. Junghans et al., Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: An open pilot study, CEREB DIS, 12(4), 2001, pp. 308-312

Authors: Junghans, U Seitz, RJ Wittsack, HJ Aulich, A Siebler, M

Citation: U. Junghans et al., Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: Report of four cases, RADIOLOGY, 221(3), 2001, pp. 795-801

Authors: Lauer, B Stahl, F Junghans, U Kluge, R Schuler, G

Citation: B. Lauer et al., Percutaneous myocardial laser-revascularization. A new therapy for patients with end-stage coronary heart disease and refractory angina pectoris, DEUT MED WO, 125(13), 2000, pp. 377-382

Authors: Huston, JP Weth, K Silva, AD Junghans, U Muller, HW Hasenohrl, RU

Citation: Jp. Huston et al., Facilitation of learning and long-term ventral pallidal-cortical cholinergic activation by proteoglycan biglycan and chondroitin sulfate C, NEUROSCIENC, 100(2), 2000, pp. 355-361

Authors: Kappler, J Franken, S Junghans, U Hoffmann, R Linke, T Muller, HW Koch, KW

Citation: J. Kappler et al., Glycosaminoglycan-binding properties and secondary structure of the C-terminus of netrin-1, BIOC BIOP R, 271(2), 2000, pp. 287-291

Authors: Lauer, B Junghans, U Stahl, F Kluge, R Oesterle, SN Schuler, G

Citation: B. Lauer et al., Catheter-based percutaneous myocardial laser revascularization in patientswith end-stage coronary artery disease, J AM COL C, 34(6), 1999, pp. 1663-1670